Rami Khalil (Member); Andrew Don-Wauchope
|Name||Position||Country||Term||Time in Office|
|A. Zemlin||Chair||ZA||2nd||2021 01 - 2023 12|
|A. Don-Wauchope||Member||CA||2nd||2021 01 - 2023 12|
|R. Khalil||Member||EG||1st||2020 03 - 2022 12|
|S. Barghava||Member||IN||2nd||2022 01 - 2024 12|
|H. Sharrod-Cole||Member||UK||1st||2022 04 - 2024 12|
|N. Giménez Gomez||Consultant||ES|
The main aim of the website of the Committee on Evidence-based Laboratory Medicine (C-EBLM) of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) is to disseminate information about Evidence-based Laboratory Medicine (EBLM) in general, and about the activities of the C-EBLM, in particular.
Our general objective is to encourage the IFCC community to get more involved in the education and practice of evidence-based laboratory medicine. Key objectives are to provide:
The C-EBLM website is primarily targeted at the IFCC community of laboratory professionals, member organisations and corporate members. However, the website may be useful for physicians and other healthcare professionals, and for EBM - related organisations, interested in the evidence-base of laboratory diagnosis.
Editor: Robert Christenson.
Editorial team: The content of the website is peer-reviewed and updated by members and associate members of the C-EBLM (see Committee membership)
If you have any problems with the use of this website or if you wish to send your comments to the editorial team, please contact the editor at email@example.com
Dr Annalise Zemlin
Division of Chemical Pathology
NHLS and Stellenbosch University
PO Box 19113
Cape Town, 7505